A Family Run Company
ChiRhoClin, Inc., a Maryland based family run corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products.
Leadership
Mission
- Develop orphan theranostic drug products for the Gastrointestinal, Pediatric, and Radiological community that will diagnose or treat pancreatic and gastrointestinal diseases.
- Create a culture of scientific exchange emphasizing research in acute and chronic pancreatitis, pancreatic cancer, gastrointestinal imaging, and genetic testing.
- Donate time, energy, and resources to encourage pancreatic research though our pancreatic grant program.
ChiRhoStim®
ChiRhoClin, Inc. received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin. Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market ChiRhoStim® (Synthetic Human Secretin for injection).
